非小细胞肺癌CT上放射性肺密度变化:剂量提升水平或体积无影响
分析59例IB–III期非小细胞肺癌患者(随机接受全原发肿瘤boost或50% SUVmax体积整合boost)3个月随访CT的肺实质密度变化。EQD2-ΔHU呈S形曲线,60 Gy以上ΔHU饱和,boost剂量分布与低剂量区ΔHU无交互作用,右肺位置为ΔHU独立危险因素(P = .02)。
要点
- 60 Gy EQD2以上肺密度变化(ΔHU)出现饱和。
- boost剂量分布(D1cc和V70Gy)与低剂量区ΔHU无交互作用。
- 右肺位置是ΔHU的独立危险因素(P = .02)。
核心结论
- 对于接受(同步或序贯化)放疗的非小细胞肺癌患者,3个月随访时60 Gy EQD2以上未见肺密度变化明显增加。
- 肺实质周边观察到的轻度反应或可在计划优化流程中加以利用以最小化肺损伤。
研究设计与样本
- PET-boost试验(NCT01024829)中59例IB至III期非小细胞肺癌患者,随机分为全原发肿瘤boost组与50% SUVmax体积整合boost组。
- 患者接受同步或序贯放化疗或单纯放疗。
- 采用形变配准将3个月随访CT映射至计划CT,提取Hounsfield单位差值(ΔHU)评估肺实质密度变化。
- EQD2-ΔHU反应以S形曲线描述,并通过极坐标分析研究区域反应差异。
- 通过广义线性模型获取ΔHU的预后因素。
主要发现
- ΔHU在60 Gy以上出现饱和。
- boost剂量分布(D1cc和V70Gy)与低剂量区ΔHU之间未发现交互作用。
- ΔHU在肿瘤周边最低,在距肿瘤边界3 cm后部达峰值(3.1 HU/Gy)。
- 右肺位置是ΔHU的独立危险因素(P = .02)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Dose-escalation for patients with non-small cell lung cancer (NSCLC) in the positron emission tomography (PET)-boost trial (NCT01024829) exposes portions of normal lung tissue to high radiation doses. The relationship between lung parenchyma dose and density changes on computed tomography (CT) was analyzed. MATERIALS AND METHODS: The CT scans of 59 patients with stage IB to III NSCLC, randomized between a boost to the whole primary tumor and an integrated boost to its 50% SUVmax (maximum standardized uptake value) volume. Patients were treated with concurrent or sequential chemoradiation or radiation only. Deformable registration mapped the 3-month follow-up CT to the planning CT. Hounsfield unit differences (ΔHU) were extracted to assess lung parenchyma density changes. Equivalent dose in 2 Gy fractions (EQD2)-ΔHU response was described sigmoidally, and regional response variation was studied by polar analysis. Prognostic factors of ΔHU were obtained through generalized linear modeling. RESULTS: Saturation of ΔHU was observed above 60 Gy. No interaction was found between boost dose distribution (D1cc and V70Gy) and ΔHU at lower doses. ΔHU was lowest peripherally from the tumor and peaked posteriorly at 3 cm from the tumor border (3.1 HU/Gy). Right lung location was an independent risk factor for ΔHU (P = .02). CONCLUSIONS: No apparent increase of lung density changes at 3-month follow-up was observed above 60 Gy EQD2 for patients with NSCLC treated with (concurrent or sequential chemo) radiation. The mild response observed peripherally in the lung parenchyma might be exploited in plan optimization routines minimizing lung damage.
引用
- Defraene G, La Fontaine M, van Kranen S, et al. Radiation-Induced Lung Density Changes on CT Scan for NSCLC: No Impact of Dose-Escalation Level or Volume. Int J Radiat Oncol Biol Phys. 2018. PMID: 30244882. doi:10.1016/j.ijrobp.2018.06.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。